title: Transient reactivation of occult hepatitis B virus infection despite lamivudine prophylaxis in a patient treated for non-Hodgkin lymphoma.
abstract: A female patient with non-Hodgkin lymphoma who tested positive for surface antigen of the hepatitis B virus and negative for hepatitis B core antibody experienced a reactivation of occult HBV infection 20 months after rituximab discontinuation despite lamivudine prophylaxis covering the 4 months of rituximab administration and the subsequent 12 months.
authors.affiliation: Department of Public Medicine, Section of Infectious Diseases, Second University of Naples, Via L. Armanni 5, 80131, Naples, Italy.
authors.forename: Gilda
authors.initials: G
authors.lastname: Tonziello
authors.forename: Marintonietta
authors.initials: M
authors.lastname: Pisaturo
authors.forename: Antonello
authors.initials: A
authors.lastname: Sica
authors.forename: Maria Giovanna
authors.initials: MG
authors.lastname: Ferrara
authors.forename: Caterina
authors.initials: C
authors.lastname: Sagnelli
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Pasquale
authors.forename: Evangelista
authors.initials: E
authors.lastname: Sagnelli
authors.forename: Salvatore
authors.initials: S
authors.lastname: Guastafierro
authors.forename: Nicola
authors.initials: N
authors.lastname: Coppola
mesh_terms: D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D004279:DNA, Viral / Q000097:blood; D005260:Female; D006509:Hepatitis B / Q000150:complications / Q000188:drug therapy* / Q000821:virology; D006515:Hepatitis B virus / Q000502:physiology*; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000150:complications / Q000188:drug therapy; D019562:Viral Load; D014775:Virus Activation
chemical_list: D000998:Antiviral Agents; D004279:DNA, Viral